Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | NVP-TAE684 | 0.0016596 | uM | 2 | 156.25 | 73.46 | 227.67 | 175.67 | 1.2937 | 1.4694 |
MDA-MB-231 | NVP-TAE684 | 0.0033113 | uM | 2 | 156.25 | 73.46 | 195.67 | 175.67 | 1.0983 | 1.1282 |
MDA-MB-231 | NVP-TAE684 | 0.01 | uM | 2 | 156.25 | 73.46 | 255.33 | 175.67 | 1.4734 | 1.7803 |
MDA-MB-231 | NVP-TAE684 | 0.031623 | uM | 2 | 156.25 | 73.46 | 184.33 | 175.67 | 1.0667 | 1.1371 |
MDA-MB-231 | NVP-TAE684 | 0.1 | uM | 2 | 156.25 | 73.46 | 182.67 | 175.67 | 1.0631 | 1.1248 |
MDA-MB-231 | NVP-TAE684 | 0.31623 | uM | 2 | 156.25 | 73.46 | 201.67 | 175.67 | 1.1696 | 1.3066 |
MDA-MB-231 | NVP-TAE684 | 1 | uM | 2 | 156.25 | 73.46 | 118.33 | 175.67 | 0.6790 | 0.4568 |
MDA-MB-231 | NVP-TAE684 | 3.1623 | uM | 2 | 156.25 | 73.46 | 51.33 | 175.67 | 0.2969 | -0.2567 |
MDA-MB-231 | NVP-TAE684 | 10 | uM | 2 | 156.25 | 73.46 | 47.33 | 175.67 | 0.2762 | -0.3010 |
MDA-MB-231 | Palbociclib | 0.0033113 | uM | 2 | 156.25 | 73.46 | 217.00 | 178.33 | 1.1977 | 1.2740 |
MDA-MB-231 | Palbociclib | 0.01 | uM | 2 | 156.25 | 73.46 | 214.67 | 178.33 | 1.1962 | 1.2935 |
MDA-MB-231 | Palbociclib | 0.031623 | uM | 2 | 156.25 | 73.46 | 127.67 | 178.33 | 0.7185 | 0.5370 |
MDA-MB-231 | Palbociclib | 0.1 | uM | 2 | 156.25 | 73.46 | 137.33 | 178.33 | 0.7653 | 0.6052 |
MDA-MB-231 | Palbociclib | 0.31623 | uM | 2 | 156.25 | 73.46 | 86.67 | 178.33 | 0.4987 | 0.1543 |
MDA-MB-231 | Palbociclib | 1 | uM | 2 | 156.25 | 73.46 | 66.33 | 178.33 | 0.3810 | -0.0732 |
MDA-MB-231 | Palbociclib | 3.1623 | uM | 2 | 156.25 | 73.46 | 80.00 | 178.33 | 0.4548 | 0.0680 |
MDA-MB-231 | Palbociclib | 10 | uM | 2 | 156.25 | 73.46 | 96.33 | 178.33 | 0.5232 | 0.1671 |
MDA-MB-231 | Palbociclib | 19.9526 | uM | 2 | 156.25 | 73.46 | 223.67 | 178.33 | 1.1888 | 1.1407 |
MDA-MB-231 | Omipalisib | 0.0016596 | uM | 2 | 312.50 | 142.67 | 387.33 | 388.50 | 0.9952 | 0.9861 |
MDA-MB-231 | Omipalisib | 0.0033113 | uM | 2 | 312.50 | 142.67 | 336.33 | 388.50 | 0.8740 | 0.8211 |
MDA-MB-231 | Omipalisib | 0.01 | uM | 2 | 312.50 | 142.67 | 398.67 | 388.50 | 1.0388 | 1.0620 |
MDA-MB-231 | Omipalisib | 0.031623 | uM | 2 | 312.50 | 142.67 | 384.33 | 388.50 | 0.9967 | 1.0072 |
MDA-MB-231 | Omipalisib | 0.1 | uM | 2 | 312.50 | 142.67 | 276.00 | 388.50 | 0.7011 | 0.5386 |
MDA-MB-231 | Omipalisib | 0.31623 | uM | 2 | 312.50 | 142.67 | 226.33 | 388.50 | 0.5942 | 0.3909 |
MDA-MB-231 | Omipalisib | 1 | uM | 2 | 312.50 | 142.67 | 151.67 | 388.50 | 0.4069 | 0.0599 |